Emotional stress as a cause of syncope and torsade de pointes in patients with long QT syndrome
Abstract
Introduction. Long QT syndrome (LQTS) is a disorder of myocardial repolarization characterized by the prolongation of QT interval and high risk propensity of torsade de pointes (TdP) that can lead to syncope, cardiac arrest and sudden death. Episodes may be provoked by various stimuli depending on the type of the condition. Case report. A 25-year-old famele patient was hospitalized due to syncope that occurred immediately after her solo concert, first time in her life. The patient studied solo singing and after intensive preparations the first solo concert was organized. Electrocardiography (ECG) on admission registered frequent ventricular premature beats (VES), followed by polymorphic ventricular tachycardia – TdP that degenerated into ventricular fibrilation (VF). After immediate cardioversion magnesium and beta-blockers were administered. TdP was registered again several times preceded by VES. The corrected QT interval (QTc) was 516 msec. For secondary prevention of sudden cardiac death, a cardioverter defibrillator was implanted, and beta-blockers continued. After a 1-year follow-up there were no recurrent episodes of TdP, and measured QTc was reduced to 484 msec. Conclusion. Patients with syncope following intensive emotional stress should be evaluated for malignant arrhythmias in the context of LQTS.
References
Hedley PL, Jørgensen P, Schlamowitz S, Wangari R, Moolman-Smook J, Brink PA, et al.. The genetic basis of long QT and short QT syndromes: a mutation update. Hum Mutat 2009; 30(11): 1486−511.
Schwartz PJ, Stramba-Badiale M, Crotti L, Pedrazzini M, Besana A, Bosi G, et al Prevalence of the congenital long-QT syndrome. Circulation 2009; 120(18): 1761−7.
Savić N, Gojković-Bukarica L. Long QT syndrome: genetic im-plications and drug influence. Vojnosanit Pregl 2008; 65(4): 308−12. (Serbian)
Schwartz PJ, Priori SG, Spazzolini C, Moss AJ, Vincent GM, Napo-litano C, et al.. Genotype-phenotype correlation in the long-QT syndrome: gene-specific triggers for life-threatening arrhyth-mias. Circulation 2001; 103(1): 89−95.
Gupta A, Lawrence AT, Krishnan K, Kavinsky CJ, Trohman RG. Current concepts in the mechanisms and management of drug-induced QT prolongation and torsade de pointes. Am Heart J 2007; 153(6): 891−9.
Medeiros-Domingo A, Itrralde-Torres P, Ackerman MJ. Clinical and genetic characteristics of lonf QT syndrome. Rev Esp Cardiol 2007; 60(7): 739−52. (Spanich)
Moric-Janiszewska E, Markiewicz-Łoskot G, Łoskot M, Weglarz L, Hollek A, Szydłowski L. Challenges of diagnosis of long-QT syndrome in children. Pacing Clin Electrophysiol 2007; 30(9): 1168−70.
Schwartz PJ, Moss AJ, Vincent GM, Crampton RS. Diagnostic cri-teria for the long QT syndrome. An update. Circulation 1993; 88(2): 782−4.
Zhang L, Timothy KW, Vincent GM, Lehmann MH, Fox J, Giuli LC, et al. Spectrum of ST-T-wave patterns and repolarization parameters in congenital long-QT syndrome: ECG findings identify genotypes. Circulation 2000; 102(23): 2849−55.
Sanguinetti MC, Jiang C, Curran ME, Keating MT. A mechanistic link between an inherited and an acquired cardiac arrhythmia: HERG encodes the IKr potassium channel. Cell 1995; 81(2): 299−307.
Wang S, Xu D, Cai J, Huang Y, Zou J, Cao K. Rapid component I(Kr) of cardiac delayed rectifier potassium currents in guinea-pig is inhibited by alpha(1)-adrenoreceptor activation via pro-tein kinase A and protein kinase C-dependent pathways. Eur J Pharmacol 2009; 608(1−3): 1−6.
Zankov DP, Yoshida H, Tsuji K, Toyoda F, Ding WG, Matsuura H, et al. Adrenergic regulation of the rapid component of delayed rectifier K+ current: implications for arrhythmogenesis in LQT2 patients. Heart Rhytm 2009; 6(7): 1038−46.
Shimizu K, Miura Y, Meguro Y, Noshiro T, Ohzeki T, Kusakari T, Imai Y. QT prolongation with torsade de pointes in pheoch-romocytoma. Am Heart J 1992; 124(1): 235−9.
Breithardt OA, Flachskampf FA, Klues HG. Life threatening acute complications of dobutamine-atropine stress echocardi-ography--a case report. Z Kardiol 1998; 87(6): 492−8.
Chockalingam P, Crotti L, Girardengo G, Johnson JN, Harris KM, Hauer RN. Not all beta-blockers are equal in the management of long QT syndrome types 1 and 2: higher recurrence of events under metoprolol. Am Coll Cardiol 2012; 60(20): 2092−9.
Daubert JP, Grant AO, Nilsson KR. Novel Insights Into Beta-Blocker Therapy for Long QT Syndromes. Am Coll Cardiol 2012; 60(20): 2100−2.
Zipes DP, Camm AJ, Borggrefe M, Buxton AE, Chaitman B, Fromer M, et al. ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force and the European Society. Circulation 2006; 114(10): 385−484.
